The global market for Cell Cryopreservation was estimated at US$10.8 Billion in 2024 and is projected to reach US$31.4 Billion by 2030, growing at a CAGR of 19.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Cell Cryopreservation market.
Additionally, the increasing number of clinical trials focused on regenerative treatments, immunotherapies, and gene-editing technologies has further driven the need for high-quality cryopreservation solutions. Hospitals, research institutions, and biotechnology companies rely on cryopreservation to store and transport viable cells for use in future medical applications. As demand grows for cell-based treatments in oncology, neurology, and reproductive health, the cell cryopreservation market is poised for continued expansion.
Another major breakthrough is the use of AI-driven monitoring systems and automated liquid nitrogen storage facilities. These technologies ensure optimal temperature control, minimize sample degradation, and provide real-time tracking of stored cells. Additionally, advancements in cryoprotective agents are reducing toxicity risks while improving post-thaw cell recovery. The integration of blockchain for data security and traceability in biobanking is also gaining traction, enhancing transparency and compliance in cryopreservation processes. With continuous improvements in freezing protocols and storage infrastructure, cell cryopreservation is becoming more efficient, scalable, and accessible across multiple medical and research fields.
Another key trend influencing market growth is the expansion of biobanking initiatives. Governments and research institutions are investing in large-scale biorepositories to support genomic research, drug discovery, and personalized medicine. The rise of decentralized cryopreservation services, which enable remote collection and storage of biological samples, is also gaining traction. Additionally, regulatory advancements in biobanking and cell therapy manufacturing are shaping the industry, ensuring compliance with Good Manufacturing Practices and ethical guidelines. As the need for cell preservation grows across various sectors, the market is expected to experience significant expansion in the coming years.
Another crucial driver shaping the market is the increasing awareness and adoption of fertility preservation services. With delayed parenthood becoming more common, demand for cryopreserved reproductive cells has surged, leading to the expansion of fertility clinics and biobanks worldwide. Additionally, government support for stem cell research and regenerative medicine initiatives is fueling investments in cryopreservation infrastructure. As new therapeutic applications continue to emerge, the need for reliable, high-quality cell cryopreservation solutions will remain strong, positioning the market for sustained growth in the years ahead.
Segments: Product (Cell Cryopreservation Consumables, Cell Freezing Media, Cell Cryopreservation Equipment); Application (Stem Cells Application, Oocytes and Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application, Other Applications); End-Use (IVF Clinics End-Use, Biopharmaceutical and Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Cell Cryopreservation Market - Key Trends & Drivers Summarized
Why Is the Demand for Cell Cryopreservation Increasing?
The demand for cell cryopreservation is increasing due to the rapid growth of regenerative medicine, biopharmaceutical research, and cell-based therapies. Cryopreservation is a critical process in storing biological materials such as stem cells, immune cells, reproductive cells, and genetically modified cells for long-term use in research and clinical applications. With the rising adoption of personalized medicine and advancements in stem cell therapy, the need for reliable cryopreservation techniques has become essential for ensuring cell viability and functionality.Additionally, the increasing number of clinical trials focused on regenerative treatments, immunotherapies, and gene-editing technologies has further driven the need for high-quality cryopreservation solutions. Hospitals, research institutions, and biotechnology companies rely on cryopreservation to store and transport viable cells for use in future medical applications. As demand grows for cell-based treatments in oncology, neurology, and reproductive health, the cell cryopreservation market is poised for continued expansion.
How Are Technological Advancements Improving Cell Cryopreservation?
Innovations in cryoprotectant formulations, automated freezing systems, and cryogenic storage solutions are enhancing the efficiency and reliability of cell cryopreservation. One of the most significant advancements is the development of vitrification techniques, which prevent ice crystal formation and improve the survival rates of cryopreserved cells. Unlike traditional slow-freezing methods, vitrification allows for ultra-rapid freezing, preserving cellular integrity and reducing the risk of cryo-injury.Another major breakthrough is the use of AI-driven monitoring systems and automated liquid nitrogen storage facilities. These technologies ensure optimal temperature control, minimize sample degradation, and provide real-time tracking of stored cells. Additionally, advancements in cryoprotective agents are reducing toxicity risks while improving post-thaw cell recovery. The integration of blockchain for data security and traceability in biobanking is also gaining traction, enhancing transparency and compliance in cryopreservation processes. With continuous improvements in freezing protocols and storage infrastructure, cell cryopreservation is becoming more efficient, scalable, and accessible across multiple medical and research fields.
Which Market Trends Are Driving Growth in the Cell Cryopreservation Industry?
The increasing demand for stem cell banking and regenerative medicine is one of the most influential trends shaping the cell cryopreservation market. Stem cell therapies for conditions such as spinal cord injuries, autoimmune disorders, and heart disease require long-term storage of viable cells, driving investments in cryopreservation technologies. Additionally, fertility preservation has emerged as a major growth area, with more individuals opting to freeze eggs, sperm, and embryos for future reproductive use.Another key trend influencing market growth is the expansion of biobanking initiatives. Governments and research institutions are investing in large-scale biorepositories to support genomic research, drug discovery, and personalized medicine. The rise of decentralized cryopreservation services, which enable remote collection and storage of biological samples, is also gaining traction. Additionally, regulatory advancements in biobanking and cell therapy manufacturing are shaping the industry, ensuring compliance with Good Manufacturing Practices and ethical guidelines. As the need for cell preservation grows across various sectors, the market is expected to experience significant expansion in the coming years.
What Are the Key Growth Drivers Shaping the Future of the Cell Cryopreservation Market?
The growth in the cell cryopreservation market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in cell-based therapies, and expanding applications in reproductive health. One of the primary growth drivers is the rising number of clinical trials for cellular immunotherapies, such as CAR-T cell therapy for cancer treatment. These therapies require stable and viable cell storage, making cryopreservation an essential component of advanced treatment protocols.Another crucial driver shaping the market is the increasing awareness and adoption of fertility preservation services. With delayed parenthood becoming more common, demand for cryopreserved reproductive cells has surged, leading to the expansion of fertility clinics and biobanks worldwide. Additionally, government support for stem cell research and regenerative medicine initiatives is fueling investments in cryopreservation infrastructure. As new therapeutic applications continue to emerge, the need for reliable, high-quality cell cryopreservation solutions will remain strong, positioning the market for sustained growth in the years ahead.
Report Scope
The report analyzes the Cell Cryopreservation market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Product (Cell Cryopreservation Consumables, Cell Freezing Media, Cell Cryopreservation Equipment); Application (Stem Cells Application, Oocytes and Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application, Other Applications); End-Use (IVF Clinics End-Use, Biopharmaceutical and Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Cell Cryopreservation Consumables segment, which is expected to reach US$19.1 Billion by 2030 with a CAGR of a 22.1%. The Cell Freezing Media segment is also set to grow at 17.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.9 Billion in 2024, and China, forecasted to grow at an impressive 26.6% CAGR to reach $7.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Cell Cryopreservation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cell Cryopreservation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Cell Cryopreservation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Avantor Inc., Biocision, LLC, BioLife Solutions Inc., Cardinal Health, Inc., Cesca Therapeutics Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 42 Featured):
- Avantor Inc.
- Biocision, LLC
- BioLife Solutions Inc.
- Cardinal Health, Inc.
- Cesca Therapeutics Inc.
- Chart Industries, Inc.
- Corning Incorporated
- Creative Biolabs
- CryoLife, Inc.
- Custom Biogenic Systems
- Danaher Corporation
- GE Healthcare
- Helmer Scientific
- HiMedia Laboratories
- Lonza Group Ltd.
- Merck KGaA
- Organ Recovery Systems Inc.
- PromoCell GmbH
- Sartorius AG
- Sigma-Aldrich Co. LLC
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Avantor Inc.
- Biocision, LLC
- BioLife Solutions Inc.
- Cardinal Health, Inc.
- Cesca Therapeutics Inc.
- Chart Industries, Inc.
- Corning Incorporated
- Creative Biolabs
- CryoLife, Inc.
- Custom Biogenic Systems
- Danaher Corporation
- GE Healthcare
- Helmer Scientific
- HiMedia Laboratories
- Lonza Group Ltd.
- Merck KGaA
- Organ Recovery Systems Inc.
- PromoCell GmbH
- Sartorius AG
- Sigma-Aldrich Co. LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 387 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 10.8 Billion |
| Forecasted Market Value ( USD | $ 31.4 Billion |
| Compound Annual Growth Rate | 19.4% |
| Regions Covered | Global |
